Personalized Medicine in Ovarian Cancer: A Perspective From Mexico.

World J Oncol

Innbiogem SC/Vitagenesis SA at National Laboratory for Services of Research, Development, and Innovation for the Pharma and Biotech Industries (LANSEIDI) of CONACyT Vitaxentrum Group, Monterrey, Nuevo Leon, Mexico.

Published: August 2021

Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on "omic" tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country's health system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297048PMC
http://dx.doi.org/10.14740/wjon1383DOI Listing

Publication Analysis

Top Keywords

personalized medicine
8
ovarian cancer
8
medicine ovarian
4
cancer perspective
4
perspective mexico
4
mexico ovarian
4
cancer represents
4
represents serious
4
serious health
4
health problem
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!